Characteristics of and treatment outcomes in rifampicin-intolerant patients

Characteristics of and treatment outcomes in rifampicin-intolerant patients

BACKGROUND: Rifampicin (RIF) is considered the backbone of TB treatment, but adverse effects often limit its use. METHODS: This retrospective cohort study examined patients treated for TB disease at our institution, and compared those who received RIF to those who were intolerant to RIF. RESULTS: A...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Mangat, S.K. Brode, H.K. Mah, M.S. Brar, N.F. Sabur
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-04-01
Series:IJTLD Open
Subjects:
tuberculosis treatment
treatment intolerance
rif
rifabutin
adverse effects
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000004/art00003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items